Titlebook: Genitourinary Cancers; Siamak Daneshmand,Kevin G. Chan Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Genito

審問,審訊

U. Wollina,M. Gebhardt,D. Lange are capable of reproducibly predicting patient outcomes. Future management of bladder cancer will likely incorporate such prognostic molecular models for risk stratification and treatment personalization.

Fissure

多樣

Molecular Prognostication in Bladder Cancer, are capable of reproducibly predicting patient outcomes. Future management of bladder cancer will likely incorporate such prognostic molecular models for risk stratification and treatment personalization.

Organization

NATTY

Carmen I. Hernandez Lara BS, PhDr greater certainty for cancer control, but at the risk of significant urinary and/or sexual morbidity. Conversely, AS preserves genitourinary function and quality of life in exchange for burdensome surveillance and the psychological impact of living with cancer.

陳列

Miscellaneous Drug-related Adverse Effects,ous blood-based analytes, provide a method of patient evaluation with potential applications in virtually all disease states. In this review, we will describe current approaches with a particular focus on demonstrated clinical utility in the evaluation and management of prostate cancer.

不真

預(yù)示

SPURN

緯線

Advances in the Treatment of Metastatic Renal Cell Carcinoma,ad resurgence with the FDA approval of nivolumab with ipilimumab. In the current chapter, we attempt to contextualize available frontline therapies for metastatic renal cell carcinoma with a focus on the CABOSUN and CheckMate 214 clinical trials.